In addition, quercetin functions as a selective METTL3 inhibitor, exhibiting an IC50 of 2.73 μM, and demonstrates dose-dependent attenuation of m6A levels in pancreatic cancer cells [262]. Here, METTL3 is linked to familial pancreatic carcinoma.